Molecules 2010, 15
2122
2. Liu, D.Y.; Luo, M.; Xie, B.F.; Feng, G.K.; Zhu, X.F.; Liu, Z.C. Antitumor effects of ampelopsin,
in Chinese. Chin. J. Cancer. 2001, 20, 1372–1375.
3. Ye, J.T.; Guan, Y.Y.; Zeng, S.; Liu, D.Y. Ampelopsin prevents apoptosis induced by H2O2 in
MT-4 lymphocytes. Planta Med. 2008, 74, 252–257.
4. Luo, G.Q.; Zeng S.; Liu, D.Y. Inhibitory effects of ampelopsin on angiogenesis, in Chinese.
Zhong Yao Cai. 2006, 29, 146–150.
5. Ruan, L.P.; Yu, B.Y.; Fu, G.M.; Zhu, D.N. Improving the solubility of ampelopsin by solid
dispersions and inclusion complexes. J. Pharm. Biomed. Anal. 2005, 38, 457–464.
6. Murakami, T.; Zhou, Y.Y. Novel dihydroflavonol compound useful for preventing inflammation,
allergy, aging, wrinkle, liver spot-freckles and drying of skin. Jpn Kokai Tokkyo Koho JP
2008007449-A, 2008, Derwent Primary Accession Number: 2008, E37987.
7. Ji, M.; Shannon, H.J.; Sidney, M.H. A dihydroflavonol glucoside from Commiphora africana that
mediates DNA strand scission. J. Nat. Prod. 2005, 68, 115–117.
8.
Liao,S.Y.; Chen, J.C.; Qian, L. QSAR, action mechanism and molecular design of flavone and
isoflavone derivatives with cytotoxicity against Hela. Eur. J. Med. Chem. 2008, 43, 2159–2170.
9. Tsoukala, E.; Agelis, G.; Dolinsek, J.; Botic, T.; Cencic, A.; Komiotis, D. An efficient synthesis
of 3-fluoro-5-thio-xylofuranosyl nucleosides of thymine, uracil, and 5-fluorouracil as potential
antitumor or/and antiviral agents. Bioorg. Med. Chem. 2007, 15, 3241–3247.
10. Saniger, E.; Campos, J.M.; Entrena, A.; Marchal, J.A.; Suárez, I.; Aránega, A.; Choquesillo, D.;
Niclós, J.; Gallo, M.Á.; Espinosa, A. Medium benzene-fused oxacycles with the 5-fluorouracil
moiety: Synthesis, antiproliferative activities and apoptosis induction in breast cancer cells.
Tetrahedron 2003, 59, 5457–5467.
11. Griffon, J.F.; Mathé, C.; Faraj, A.; Aubertin A.M.; De Clercq E.; Balzarini J.; Sommadossi J.P.;
Gosselin G.. Stereospecific synthesis and biological evaluations of β-L-pentofuranonucleoside
derivatives of 5-fluorouracil and 5-fluorocytosine. Eur. J. Med. Chem. 2001, 36, 447–460.
12. Domınguez, J.F.; Marchal, J.A.; Correa, A.; Carrillo, E.; Boulaiz, H.; Aranega, A.; Gallo, M.A.;
Espinosa, A. Synthesis and evaluation of new 5-fluorouracil antitumor cell differentiating
derivatives. Bioorg. Med. Chem. 2003, 11, 315–323.
13. Heidelberger, C.; Chaudhuri, N. K.; Danneberg, P.; Mooren, D.; Griesbach, L. Fluorinated
pyrimidines, a new class of tumour-inhibitory compounds. Nature 1957, 179, 663–666.
14. Zhang, F.M.; Yao, X.J.; Tian, X.; Tu, Y.Q. Synthesis and biological evaluation of new 4β-5-Fu-
substituted 4'-demethylepipodophyllotoxin derivatives. Molecules 2006, 11, 849–857.
15. Cai, T.B.; Tang, X.; Nagorski, J.; Brauschweiger, P.G.; Wang, P.G. Synthesis and cytotoxicity of
5-fluorouracil/diazeniumdiolate conjugates. Bioorg. Med. Chem. 2003, 11, 4971–4975.
16. Bounous, G.; Pageau, R.; Regoli, D. Enhanced 5-fluorouracil mortality in rats eating defined
formula diets. Int. J. Clin. Pharmacol. Biopharm. 1978, 16, 265–267.
17. Contino, C.; Maurizis, J.C.; Pucci, B. Synthesis and preliminary biological assessments of a new
class of amphiphilic telomers bearing 5-fluorouracil moieties. Macromol. Chem. Phys. 1999, 200,
1351–1355.
18. Nichifor, M.; Schacht, E.H.; Seymour, L.W. Polymeric prodrugs of 5-fluorouracil. J. Control.
Release 1997, 48, 165–178.